Skip to main content
. 2018 Feb 21;18(2):1–160.

Table 37:

Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Funding for Insulin, Pump, Strips, and 75% of Sensor Costs

Age,a y Year 1, $ Year 2, $ Year 3, $ Year 4, $ Year 5, $
Funding CGM Based on a Conservative Projection of a 20% Annual Increase
All ages 6,258,114 7,212,880 8,616,558 10,212,713 11,746,912
0–24 1,738,689 2,003,952 2,393,935 2,837,394 3,263,640
25–65 3,397,447 3,915,777 4,677,815 5,544,347 6,377,243
65+ 1,121,977 1,293,151 1,544,808 1,830,972 2,106,029
Funding CGM for Entire Population With Hypoglycemia Unawareness
All ages 62,186,324 63,630,543 64,296,591 64,842,725 65,295,437
0–24 17,499,740 17,721,986 17,688,562 17,646,273 17,613,612
25–65 33,898,320 34,600,771 34,804,315 34,934,408 34,960,287
65+ 10,788,265 11,307,785 11,803,714 12,262,045 12,721,538
Funding CGM for Entire Type 1 Diabetes Population
All ages 248,745,298 254,522,171 257,186,365 259,370,901 261,063,447
0–24 69,998,960 70,887,946 70,754,249 70,585,090 70,421,580
25–65 135,593,278 138,403,086 139,217,260 139,737,631 139,776,924
65+ 43,153,060 45,231,139 47,214,856 49,048,180 50,864,943

Abbreviations: CGM, continuous glucose monitoring; NBI, net budget impact.

a

Ages 0–24 years, full funding of blood glucose test strips (annual cost $1,243); 25–65 years, strips funded to a maximum $920; 65+ years, full funding of strips and $170 grant for syringes and needles.